Recent News

• 04.23.2025 - BD Launches Industry-First Bioabsorbable Mesh Designed for Umbilical Hernia Repair
• 04.23.2025 - BD Launches Industry-First Bioabsorbable Mesh Designed for Umbilical Hernia Repair
• 04.21.2025 - BD Launches Next Generation Hemodynamic Monitoring Solution Providing Clinicians with AI-Driven Clinical Decision Support
• 04.03.2025 - BD to Announce Financial Results for its Second Quarter of Fiscal 2025
• 03.31.2025 - BD Named One of America's Most Innovative Companies by Fortune
• 03.27.2025 - BD Names Gregory J. Hayes to Board of Directors
• 03.27.2025 - BD Names Gregory J. Hayes to Board of Directors
• 03.20.2025 - BD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE™ Scaffold in Breast Implant Revision Surgery
• 03.20.2025 - BD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE™ Scaffold in Breast Implant Revision Surgery

Recent Filings

• 04.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.09.2025 - 144 Report of proposed sale of securities
• 04.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.27.2025 - 8-K Current report
• 03.27.2025 - 3 Initial statement of beneficial ownership of securities
• 03.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.18.2025 - 144 Report of proposed sale of securities
• 03.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.12.2025 - 144 Report of proposed sale of securities